%0 Journal Article %T Mechanistic Learning for Combinatorial Strategies With Immuno-oncology Drugs: Can Model-Informed Designs Help Investigators? %+ Simulation and Modeling of Adaptive Response for Therapeutics in Cancer (SMARTc) %+ Hôpital de la Timone [CHU - APHM] (TIMONE) %+ Institut Gustave Roussy (IGR) %+ Direction de la recherche clinique [Gustave Roussy] %+ Modélisation Mathématique pour l'Oncologie (MONC) %+ Institut de Mathématiques de Bordeaux (IMB) %A Ciccolini, Joseph %A Barbolosi, Dominique %A André, Nicolas %A Barlesi, Fabrice %A Benzekry, Sébastien %< avec comité de lecture %@ 2473-4284 %J JCO precision oncology %I American Society of Clinical Oncology %V 108 %N 4 %P 486-491 %8 2020-09 %D 2020 %R 10.1200/PO.19.00381 %Z Computer Science [cs]/Modeling and Simulation %Z Life Sciences [q-bio]/Cancer %Z Physics [physics]/Physics [physics]/Data Analysis, Statistics and Probability [physics.data-an] %Z Life Sciences [q-bio]/Santé publique et épidémiologie %Z Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology %Z Statistics [stat]/Applications [stat.AP]Journal articles %X The amount of 'big' data generated in clinical oncology, whether from molecular, imaging, pharmacological or biological origin, brings novel challenges. To mine efficiently this source of information, mathematical models able to produce predictive algorithms and simulations are required, with applications for diagnosis, prognosis, drug development or prediction of the response to therapy. Such mathematical and computational constructs can be subdivided into two broad classes: biologically agnostic, statistical models using artificial intelligence techniques, and physiologically-based, mechanistic models. In this review, recent advances in the applications of such methods in clinical oncology are outlined. These include machine learning applied to big data (omics, imaging or electronic health records), pharmacometrics, quantitative systems pharmacology, tumor size kinetics, and metastasis modeling. Focus is set on studies with high potential of clinical translation, as well as applied to cancer immunotherapy. Perspectives are given in terms of combinations of the two approaches: 'mechanistic learning'. %G English %2 https://inria.hal.science/hal-03147084/document %2 https://inria.hal.science/hal-03147084/file/final.pdf %L hal-03147084 %U https://inria.hal.science/hal-03147084 %~ INSERM %~ CNRS %~ INRIA %~ UNIV-AMU %~ INRIA-BORDEAUX %~ SANTE_PUB_INSERM %~ INRIA_TEST %~ FNCLCC %~ BERGONIE %~ IGR %~ PAOLI_CALMETTES %~ TESTALAIN1 %~ TESTBORDEAUX %~ INRIA2 %~ TDS-MACS %~ CRCM %~ INRIAARTDOI